Need for an addendum on the clinical investigation of medicinal products intended for treatment of glucocorticoid-induced osteoporosis - Scientific guideline
HumanScientific guidelines
On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.
This document reflects the need for an addendum on glucocorticoid-induced osteoporosis to the guideline on the clinical investigation of medicinal products used in the treatment of osteoarthritis.
Keywords: Osteoporosis, glucocorticoids, secondary osteoporosis, postmenopausal osteoporosis, endpoints